Headlines

Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.

Stock Highlights: ImmunoGen, Inc. (NASDAQ:IMGN), Huntington Bancshares Incorporated (NASDAQ:HBAN), Ohio Valley Banc Corp. (NASDAQ:OVBC), SMTP, Inc. (NASDAQ:SMTP), Gol Linhas Aereas Inteligentes (NYSE:GOL)

Kristen Barton02 mins

On Oct. 28, Ventana Medical Systems, Inc. announced it has entered into an agreement with ImmunoGen, Inc. (NASDAQ:IMGN) to collaborate on the development of biomarker assays and a companion diagnostic immunohistochemistry (IHC) test for one or more of ImmunoGen’s product candidates. ImmunoGen, Inc. (NASDAQ:IMGN) belongs to Healthcare sector. Its weekly performance is 5.83%. On last…

Read More

Skyworks Reports 2Q Earnings, Expects Solid 2H Growth

Kristen Barton02 mins

Skyworks Solutions reported healthy fiscal second quarter earnings. Although the company gave investors a third-quarter outlook that was modestly below our expectations, it hinted at nice growth in the second half of calendar 2013. Skyworks’ revenue was $425 million in the March quarter, slightly above the outlook of $420 million as discussed by management in…

Read More

Dupont Meets Expectations but Chemicals Business Struggles

Kristen Barton02 mins

On Tuesday, DuPont reported third-quarter results that generally matched our expectations. DuPont experienced year-over-year operating earnings improvement in all of its segments except performance chemicals. We’re raising our fair value estimate to $57 per share from $55 to account for slight modifications to our forecast and the effect of the time value of money since…

Read More
Home